Matheus Séverine, Houcke Stéphanie, Lontsi Ngoulla Guy Roger, Higel Nicolas, Ba Abesetou, Cook Fabrice, Gourjault Cyrille, Nkontcho Flaubert, Demar Magalie, Nacher Mathieu, Djossou Félix, Hommel Didier, Résiere Dabor, Pujo Jean Marc, Kallel Hatem
Intensive Care Unit, Cayenne General Hospital, Cayenne 97300, French Guiana.
Pharmacy Department, Cayenne General Hospital, Cayenne 97300, French Guiana.
Trop Med Infect Dis. 2024 Jan 5;9(1):15. doi: 10.3390/tropicalmed9010015.
(1) Background: Until December 2021, French Guiana (FG), located in South America, faced four consecutive COVID-19 epidemic waves. This study sought to analyze the mortality trend of severe COVID-19 patients admitted to the referral ICU of FG. (2) Methods: We conducted a prospective, observational, and non-interventional study in ICU at Cayenne Hospital. We included 383 patients older than 18 admitted with SARS-CoV-2-related pneumonia hospitalized from May 2020 to December 2021. The study covers three periods. Period 1 (Waves 1 and 2, original variant), period 2 (Wave 3, Gamma variant), and period 3 (Wave 4, Delta variant). (3) Results: The median age was 63 years (52-70). Frailty was diagnosed in 36 patients over 70 (32.4%). Only 4.8% of patients were vaccinated. The median ICU LOS was 10 days (6-19). Hospital mortality was 37.3%. It was 30.9% in period 1, 36.6% in period 2 ( = 0.329 vs. period 1), and 47.1% in period 3 (0.015 vs. period 1). In multivariate analysis, independent factors associated with hospital mortality included age greater than 40 years (]40-60 years] OR = 5.2, 95%CI: 1.4-19.5; (]60-70 years] OR = 8.5, 95%CI: 2.2-32; (]70+ years] OR = 17.9, 95%CI: 4.5-70.9), frailty (OR = 5.6, 95%CI: 2.2-17.2), immunosuppression (OR = 2.6, 95%CI: 1.05-6.7), and MV use (OR = 11, 95%CI: 6.1-19.9). This model had an overall sensitivity of 72%, a specificity of 80.4%, a positive predictive value of 68.7%, and a negative predictive value of 82.8%. (4) Conclusions: The mortality of severe COVID-19 patients in French Amazonia was higher during the Delta variant wave. This over-death could be explained by the virulence of the responsible SARS-CoV-2 variant and the under-vaccination coverage of the studied population.
(1)背景:截至2021年12月,位于南美洲的法属圭亚那(FG)连续经历了四波新冠疫情。本研究旨在分析FG转诊重症监护病房收治的重症新冠患者的死亡率趋势。(2)方法:我们在卡宴医院的重症监护病房进行了一项前瞻性、观察性和非干预性研究。我们纳入了2020年5月至2021年12月因感染SARS-CoV-2相关肺炎入院的383名18岁以上患者。该研究涵盖三个时期。时期1(第1波和第2波,原始毒株),时期2(第3波,伽马毒株),以及时期3(第4波,德尔塔毒株)。(3)结果:中位年龄为63岁(52 - 70岁)。70岁以上的36名患者被诊断为虚弱(32.4%)。只有4.8%的患者接种了疫苗。重症监护病房的中位住院时间为10天(6 - 19天)。医院死亡率为37.3%。时期1为30.9%,时期2为36.6%(与时期1相比P = 0.329),时期3为47.1%(与时期1相比P = 0.015)。在多变量分析中,与医院死亡率相关的独立因素包括年龄大于40岁(40 - 60岁:比值比[OR]=5.2,95%置信区间[CI]:1.4 - 19.5;60 - 70岁:OR = 8.5,95%CI:2.2 - 32;70岁以上:OR = 17.9,95%CI:4.5 - 70.9)、虚弱(OR = 5.6,95%CI:2.2 - 17.2)、免疫抑制(OR = 2.6,95%CI:1.05 - 6.7)以及机械通气的使用(OR = 11,95%CI:6.1 - 19.9)。该模型的总体敏感性为72%,特异性为80.4%,阳性预测值为68.7%,阴性预测值为82.8%。(4)结论:在法属圭亚那,德尔塔毒株流行期间重症新冠患者的死亡率更高。这种额外的死亡可能是由致病的SARS-CoV-2毒株的毒力以及所研究人群的疫苗接种覆盖率低所导致的。